Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07415356
Eligibility Criteria:
Inclusion criteria:
* Patients with abdominal and/or pelvic lymph node recurrences of solid tumors.
* No more than 5 metastatic lesions in no more than 2 organs and a controlled primary tumor site.
* Diagnostic imaging includes at least a PET scan or CT thorax/abdomen, of which one is not older than 4 weeks at the time of referral for SBRT.
* Primary tumor must be treated at least 4 months before the diagnosis of metastasis.
* Patients must be 18 years or older.
* Written informed consent.
Exclusion criteria:
* Prior radiotherapy in the same field.
* Second primary malignancy except in situ carcinoma of the cervix, adequately treated non-melanoma skin cancer, or other malignancy treated at least 3 years.
* Serious concomitant systemic disorders that would compromise the safety of the patient or his/her ability to complete the study, at the discretion of the investigator.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07415356
Study Brief:
Protocol Section:
NCT07415356